LOADING
Comparing Tesla Inc (TSLA) and Merck & Company (MRK) across the Consumer Discretionary and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TSLA | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.46T | $356.0B |
| P/E Ratio | 333.9 | 114.5 |
| Forward P/E | 158.7 | 15.3 |
| PEG Ratio | 4.54 | 2.71 |
| EPS | $1.11 | $1.26 |
| Revenue Growth (YoY) | 25.5% | 5.1% |
| Profit Margin | 3.7% | 4.8% |
| Return on Equity | 4.7% | 7.0% |
| Dividend Yield | -- | 2.31% |
| Beta | 1.84 | 0.23 |
| 52-Week High | $498.83 | $156.00 |
| 52-Week Low | $297.38 | $79.67 |
| Volume | -- | -- |
Tesla Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.